Medifocus, Inc. is a medical technology company based in Columbia, MD, specializing in the development and commercialization of minimally invasive tumor treatment devices and systems. With a focus on breast cancer care, Medifocus utilizes focused microwave heating to enhance neoadjuvant chemotherapy, leading to improved tumor shrinkage and surgical outcomes, ultimately aiming for breast preservation. Through their patented adaptive phased array microwave focusing technology, licensed from MIT, Medifocus designs unique focused heat treatment systems that precisely target tumors, inducing hyperthermia to shrink or eradicate them without causing harm to surrounding tissue. Additionally, the company has acquired the Prolieve Thermodilatation System Assets, an FDA-approved device for the treatment of Benign Prostatic Hyperplasia (BPH), providing revenue from its sales. Medifocus strives to improve cancer treatment outcomes and standards of care, offering innovative solutions for locally advanced breast cancer and BPH.Generated from the website